Second consensus conference organized by SEMIUC. Response to aggression: Evaluation and therapeutical implications;Segunda Conferencia de Consenso Organizada por la SEMIUC: Respuesta a la agresion: Valoracion e implicaciones terapeuticas

Medicina Intensiva

Volumn 21, Issue 1, 1997, Pages 13-28

  Garcia De Lorenzo Y Mateos A ^a   Ortiz Leyba, C ^a   Caparros T ^a   Padro J B ^a   Abizanda, R ^a   Ibanez J ^a   De La Cal, M A ^a   Navarro, A ^a   Culebras, J M ^a   Gomez Rubi J ^a   Herreros De Tejada, A ^a   Jimenez Torres V ^a   Vazquez C ^a   Zaldumbide, J ^a   Acosta, J ^a   Bonet, A ^a   Celaya, S ^a   Espanol T ^a   Gamacho, J ^a   Jimenez Jimenez F J ^a   Lopez Martinez J ^a   Lorente, J A ^a   Marse P ^a   Masso J ^a   Montejo, J C ^a   Ordonez J ^a   Nunez R ^a   Planas, M ^a   Salas, J ^a   Salgado, J A ^a   Sanchez C ^a   Sitges, A ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGGRESSION; CONFERENCE PAPER; SYMPOSIUM;

EID: 8044260280     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (102)

1. Abehsira-Amar O, Gilbert M, Joliy M, Theze J. Jancovic DL. IL-4 plays a dominant role in the differential development of ThO into Th1 and Th2 cells. J Immunol 1992; 148:3.820-3.829.
2. Alastrué Vidal A, Salva Lacombe JA. Valoración nutricional del paciente ingresado. En: Celaya S, ed. Nutrición Artificial Hospitalaria. Zaragoza: Venues Ed, 1989;59-92.
3. a2: 19-23. Congreso de la Sociedad Americana de Nutrición Parenteral y Enteral (ASPEN). Orlando, 1992.
4. Baker J, Detsky A, Wesson D, Wolman SL, Stewart S, White-well J, et al. A comparison on clinical judgement and objective measurements. N Engl J Med 1982; 302:969-972.
5. Barton RG. Nutrition support in critical illness. Nutr Clin Pract 1994;9:127-140.
6. Baue AE. Surgical hemostasis. En: Baue AE, ed. Multiple organ failure. St Louis: Mosby Year Book, 1990; 3-66.
7. Bone TC. Toward a theory regarding the pathogenesis of the systemic inflamatory response syndrome: What we do and do not know about cytokine regulation. Crit Care Med 1996; 24:163-172.
8. th ASPEN Congress, 1995.
9. Bursztein S, Elwyn DH, Askanazi J, Kinney JM. Energy metabolism, indirect calorimetry, and nutrition. Baltimore: Williams & Wilkins, 1989.
10. Caparrós T, García de Lorenzo A, López Martínez J. Metabolismo y nutrición en el paciente crítico. Medicine (no extra) 1991; 5:100-107.
11. Caparrós T, López Martínez J, Acosta J. Monitorización nutricional metabólica. En: Caturla J, ed. Monitorización del paciente grave. Madrid: IDEPSA, 1995; 164-181.
12. Cederholm T, Jägrén C, Hellström K. Outcome of protein-energy malnutrition in elderly medical patients. Am J Med 1995; 98:67-75.
13. Cerra FB, Holman RT, Bankey PE. Nutritional pharmacology: Its role in the hypermetabolism-organ failure syndrome. Crit Care Med 1990; 18:S154-S158.
14. Cerra FB. Hypermetabolism, organ failure, and metabolic support. Surgery 1987; 101:1-14.
15. Cerra GF, Alden PA, Negro F, Billiar T, Svingen BA, Licari J, et al. Sepsis and exogenous lipid modulation. JPEN 1988; 12:S63-68.
16. Christman JW, Holden EP, Blackvell TS. Strategies for bioking the sistemic effects of citokynes in the sepsis syndrome. Crit Care Med 1995; 23:955-963.
17. Chioléro R, Berger M. Endocrine response to brain injury. New Horizons 1994; 2:432-442.
18. Cinat ME, Waxman K, Ganger GA. Trauma causes sustained elevation of soluble tumor necrosis factor receptors. J Am Coll Surg 1994; 179:529-537.
19. Cizza G, Pacak K, Kvetnansky R, Palkovits M, Glodestein DS, Brady LS, et al. Decreased stress responsivity of central and peripheral catecolaminergic systems in aged 344/n Fischer rats. J Clin Invest 1995; 95:1.217-1.224.
20. Clowes CHA Jr, O'Donnell TF, Blackburn GF, Malu TN, Energy metabolism and proteolysis in traumatized and septic man. Surg Clin North Am 1976; 56:1.169-1.184.
21. Detsky A, Samlley P, Chang J. Is this patient malnourished? JAMA 1994; 271:54-58.
22. Doherty TM. T-cell regulation of macrophage function. Immunol 1995; 7:4.000-4.041.
23. Dunham CM, Frankenfield D, Belzberg H, Wiles CE, Cushing B, Grant Z. Inflammatory markers: superior predictors of adverse outcome in blunt trauma patients? Crit Care Med 1994; 22:667-672.
24. Elia M. Changing concepts of nutrient requirements in disease: Implications for artificial nutritional support. Lancet 1995; 345:1.279-1.284.
25. Falconer JS, Fearon KC, Plester CE, Ross JA, Carter DC. Cytoquines, the acute phase-reponse, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 1994; 219:325-331.
26. Fisher CJ Jr, Opal SM, Dhainaut JF, Stephens S, Zimmerman JL, Nightingale P, et al. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patiens with sepsis. Crit Care Med 1993; 21:318-327.
27. Fisher CJ, Slotman GJ, Opal SM. Human recombinant interleukin-1 receptor antagonist (IL-Ira) in the treatment of patients with sepsis syndrome. Cir Shock 1993; S1:42.
28. Fong Y, Lowry S. Metabolic consequences of critical illness. En: Barie PS, Shires GT, eds. Surgical Intensive Care. Boston: Little Brown Company, 1993; 893-905.
29. a. ed.). Philadelphia: W.B. Saunders Co, 1993; 597-616.
30. García de Lorenzo A, Celaya S, Culebras JM. Líneas de futuro en Nutrición Artificial. En: Celaya S, ed. Avances en Nutrición Artificial. Zaragoza: Universidad de Zaragoza, 1993; 321-344.
31. García de Lorenzo A, Celaya S, Jiménez M, Caparrós T. Respuesta orgánica a la agresión. Utilización de substratos. En: Celaya S, ed. Avances en Nutrición Artificial. Zaragoza: Universidad de Zaragoza, 1993; 1-24.
32. García de Lorenzo A, Culebras JM. Hormonas, factores de crecimiento y fármacos en el metabolismo y la nutrición. Nutr Hosp 1995; 10:297-305.
33. García de Lorenzo A, ed. Curso avanzado de soporte nutrometabólico en el paciente crítico. Madrid: Grupo Metabólico de la SEMIUC. Abbott Laboratories SA, 1995.
34. García de Lorenzo A, Gómez V, Añón JM, López J, Yus S, Jiménez M. Micronutrientes en la agresión séptica severs. Utilidad como marcadores pronósticos. Nutr Hosp 1990; 5:304-310.
35. García de Lorenzo A, Culebras JM. Nutritional and metabolic support: Converging concepts. Nutrition 1991; 7:163-167.
36. García de Lorenzo A, Grande C. Agresión quirúrgica. Patrón hormono-metabólico. Nutr Hosp 1984; Monografía 14:22-32.
37. García de Lorenzo A, Montejo JC, Planas M. Requerimientos energélicos en los pacientes críticos. Calorimetría indirecta. Med Intensiva 1995; 19:86-94.
38. García de Lorenzo A, Ortíz C, Montejo JC. Nutrición parenteral en situaciones especiales. Rev Clin Española 1994; 194:46-53.
39. García de Lorenzo A, Ortíz C, Montejo JC. Respuesta metabólica a la agresión. Clasificación del estrés metabólico. En: Caparrós Fernández de Aguilar T, ed. Soporte metabólico nutricional del paciente crítico. Madrid: IDEPSA, 1993; 1-9.
40. García de Lorenzo A, Ortíz C, Planas M, Montejo JC, Ordóñez J, Jiménez J, et al. Patrones metabólicos en el estrés. ¿Existen diferencias? Nutr Hosp 1994; 9(S):37.
41. Gore DG, O'Brien R, Reines D. Derangementes in peripheral glucose and oxygen utilization induced by catabolic hormones. Crit Care Med 1993; 21:1.712-1.716.
42. Heyland DK, Cook DJ, Guyatt GH. Does the formulation of enterai feeding products influence infectious morbidity and mortality rates in the critically ill patient? A critical reivew of the evidence. Crit Care Med 1994; 22:1.192-1.202.
43. Hoch RC, Rodríguez R, Manning T, Bishop M, Mead P, Shoemaker WC, et al. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993; 21:839-845.
44. Hotchkiss RS, Kart IE. Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA 1992; 267:1.503-1.519.
45. IL-2/IFNg. En: Callard R, Gearing A, eds. The cytokine Facts Book. London: Acad. Press, 1994; 39-40 y 157-158.
46. Infante Miranda F. Valoración del estado de nutrición. Rev Clin Esp 1994; 194:692-700.
47. Inmunología. Bases moleculares y celulares. En: Peña Martínez J, ed. Madrid: Pirámide, 1994.
48. Jacobs DO, Kobayashi T, Imagre J. Sepsis alters skeletal muscle energetics and membrane function. Surgery 1991; 110:318-326.
49. Jeejeebhoy KN. Assessment of nutritional states. En: Rombeau J, Caldwell MD, eds. Enteral and tube feeding. Philadelphia: Saunders, 1990; 118-126.
50. Jeejeebhoy KN, Baker JP, Wolman SD. Critical evaluation on the role of clinical assesment and body composition studies in patients with malnutrition and after total parenteral nutrition. Am J Clin Nutr 1982; 35:1.117-1.127.
51. Kinney JM. Metabolic response of the critically ill patient. En: Lang CH. Abumrad N, eds. Nutrition in the critically ill patient. Crit Care Clin 1995; 11:569-585.
52. Kinney JM, Tucker HN, eds. Organ metabolism and nutrition. Ideas for future critical care. New York: Raven Press, 1994.
53. Kinsella JE, Lokesh B. Dietary lipids, eicosanoids and the inmune system. Crit Care Med 1990; 18:S94-113.
54. Klurfeld DM, ed. Nutrition and immunology. New York: Plenum Press, 1993.
55. Lieberman MD, Shou J, Torres AS. Effects of nutrient substrates on immune function. Nutrition 1990; 6:88-91.
56. Lo HC, Hinton PS, Peterson CA, Ney DM. Simultaneous treatment with IGF-1 and GH additively increases anabolism in parenterally fed rats. Am J Physiol 1995; E368-376.
57. Long CL. The energy and protein requirements of the critically in patients. En: Wrighy RA, Heymsfield S, eds. Nutritional assessment. Boston: Blackwell Scientific Pub, 1984; 157-181.
58. López Martínez J, Sánchez Castilla M, Ordoñez González EJ, Temprano Vázquez S, García de Lorenzo A, Del Nogal Sáez F. Utilidad del colesterol como marcador nutrometabólico en el paciente séptico. Nutr Hosp 1995; 10:24-31.
59. López Martínez J, Sánchez Castilla M, Temprano Vázquez S, Algora Weber A, Jiménez Jiménez FJ, del Nogal Sáez F. Metabolismo del hierro en el paciente crítico. Med Intensiva 1995; 16:285-292.
60. Lowry SF. Hormone and cytokine regulation of injury metabolism. En: Vincent JL, ed. 1993 Yearbook of Intensive Care and Emergency Medicine. Berlin: Springer-Verlag, 1993; 3-11.
61. Lowry SF. Metabolic responses to anti-cytokine therapies. En: Wilmore DW, Carpentier YA, eds. Metabolic support of the critically ill patients. Berlin: Springer-Verlag, 1993; 333-346.
62. Mackiewizt, Kushn I, Baumann H. Acute phase proteins, molecular biology, biochemistry and clinical aplications. CRC Press 1993; 1-686.
63. Manning E, Shenkin A. Nutritional assessment in the critically ill. En: Lang C, Abumrad N, eds. Nutrition in the critically ill Patient. Critical Care Clinic. Philadelphia: Saunders Ed., 1995; 603-634.
64. Marsé P, ed. Nutrición enterai. Med Intensiva (Monografía) 1994; 18:379-464.
65. Martin C, Saux P, Mege JL, Perrin G, Papazian L, Govin F. Prognostic values of serum cytokines in septic shock. Intensive Care Med 1994; 20:272-277.
66. Masclans JR, Planas M, Porta I, Bermejo B, Padre JB, de Latorre F. Requerimientos energéticos en pacientes postrasplante hepático. Nutr Hosp 1993; 8:288-294.
67. Massó J, Cardona D, Sabin P. Perspectivas farmacéuticas en Nutrición Artificial. En: Celaya S, ed. Avances en Nutrición Artificial. Zaragoza: Universidad de Zaragoza. 1993; 363-386.
68. Mathes DE, Battezzati A. Regulation of protein metabolism during stress. Current Opin Gen Sur 1993; 72-77.
69. McClave SA, Snider HL. Understanding the metabolic response to critical illness: Factors that cause patients to deviate from the expected pattern of hypermetabolism. New Horizons 1994; 2:139-147.
70. Meulemann J, Katz P. The immunologic effects, kinetics and use of glucocorticosteroids. Med Clin N Am 1985; 69:805-807.
71. Michelson D, Gold PW, Stemberg EM. The stress response in critical illnes. New Horizons 1994; 2:426-431.
72. Mizock BA. Alterations in carbohydrate metabolism during stress: A review of the literature. Am J Med 1995; 98:75-84.
73. Mocchegiani E, Imberti R, Testasecca D, Zandri M, Santarelli L, Fabris N. Thyroid and thymic endocrine function and survival in severely traumatized patients with or without head injury. Intensive Care Med 1995; 21:334-341.
74. Montejo González JC, García de Lorenzo Mateos A, Celaya Pérez S. Fundamentos del tratamiento metabólico nutricional en pacientes politraumatizados. En: Alted E, ed. Atención al paciente politraumatizado. Medicina Intensiva Práctica. Madrid: IDEPSA, 1993; 197-214.
75. Nogués R, Sitges-Serra A, Sancho JJ, Sanz F, Monne J, Girvent M. et al. Influence of nutrition, thyroid hormones, and rectal temperature on in-hospital mortality of elderly patients with acute illness. Am J Clin Nutr 1995; 61:597-602.
76. Okur H, Küçükaydin M, Üstdal M. The endocrine and metabolic response to surgical stress in the neonate. J Pediatr Surg 1995; 30:626-630.
77. Pahlavani MA, Harris MD, Richardson A. The age-related decline of the induction of IL-2 transcription is correlated to changes in the transcription factor NFAT. Cell Immunol 1995; 165:84-91,
78. Pasternak CA, Aiyathurai EJ, Makinde V, Daules A, Baldwin SA, Konieczko EM. et al. Regulation of glucose uptake by stressed cells. J Cellular Physiol 1991; 149:324-331.
79. Pearce EJ, Reiner SL. Induction of Th2 responses in infectious diseases. Immunol 1995; 7:497-504.
80. Peck MD. Immunonutrition in the ICU: Rationale and efficacy. En: ASPEN. 20th Clinical Congress. Silver Spring, 1996.
81. Petros A, Bennett D, Vallance P. Effect of nitric oxide sinthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338:1.557-1.558.
82. 2 en paeientes críticos. Med Intensiva 1992; 16:204-208.
83. Rees RC. Cytokines as biological response modifiers. J Clin Pathol 1992; 45:93-98.
84. Roberts PR. Nutrition in head-injured patient. New Horizons 1995; 3:506-517.
85. Rothwell PM, Lawler PG. Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 1995; 23:78-83.
86. Roza AM, Shizgal HM. The Harris-Benedict equation revaluated: Resting energy requirements and the body cell mass. Am J Clin Nutr 1984; 40:168-182.
87. Shapiro L, Gelfrand J. Cytokines and sepsis: pathophysiology and therapy. New Horizons 1993; 1:13-22.
88. Sheakin A. Trace elements as inflamatory response: implications for nutritional support. Nutrition 1995; 11(S): 100-105.
89. Steward WP. Granulocyte and granulocyte-macrofage colony-stimulating factors. Lancet 1995; 342:153-157.
90. Stites DP. Laboratory evaluation of immune competence. En: Stites DP, Terr A, Parslow T, eds. Basic and Clinical Immunology. (8 ed.) London: Appleton and Lange 1994; 256-262.
91. Sumita S, Ujike Y, Namiki A, Watanabe H, Kawamata M, Watanabe A, et al. Suppression of the thyrotropin response to thyrotropin-releasing hormone and its association with severity of critical illness. Crit Care Med 1994; 22:1.603-1.609.
92. Teodorczyk-Injeyan JA, Cembrzynska-Nowak M, Lalani S, Rizoli S, Taylor G. Tumor necrosis factor alpha regulation of immunoglobulin secretion in trauma patients. Circ Shock 1994; 43:26-33.
93. Vamvakopoulos NC, Chrousos GP. Hormonal regulation of human corticotropin-releasing hormone gene expression: Implications for the stress response and immune/inflamatory reaction. Endocr Rev 1994; 15:409-421.
94. Voerman BJ, Strack van Schijndel RJM, de Boer H. Effects of human growth hormone on fuel utilization and mineral balance in critically ill patients on full intravenous nutritional support. J Crit Care 1994; 9:143-150.
95. Weir JBDV. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949; 109:1-9.
96. Wilmore DW, Carpentier YA. Metabolic support of the critically patiens. Berlin: Springer Verlag, 1993.
97. Wilmore DW, Catabolic illness: Strategies for enhancing recovery. N Engl J Med 1991; 325:695-702.
98. Wilmore DW. The practice of clinical nutrition: How to prepare the future. JPEN 1989; 13:337-343.
99. Williams RR, Fuenning CR. Circulatory indirect calorimetry in the critically ill. JPEN 1991; 15:509-512.
100. Wood JJ, Rodrick ML, Mclrvine AHJ, Manmick JA, Lymphocyte abnormalities associated with impaired immunological defense. En: Cloves GHA Jr, ed. Trauma, Sepsis and Shock. The Physiological Basis of Therapy. New York: Marcel Dekker, 1988; 371-422.
101. Ziegler MG, Morrissey EC, Marshall LF. Catecholamines and thyroid hormones in traumatic injury. Crit Care Med 1990; 18:253-258.
102. Ziegler TR. Growth hormone administration during nutritional support: what is to be gained? New Horizons 1994; 2:244-256.